<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Diabetes and Metabolic Disorders</JournalTitle><Volume>2</Volume><Issue>0</Issue></Journal><ArticleTitle>EFFECT OF OMEGA-3 FATTY ACIDS ON GLYCAEMIC CONTROL AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES.</ArticleTitle><FirstPage>30</FirstPage><LastPage>30</LastPage><AuthorList><Author><FirstName>Gholamhossein</FirstName><LastName>OMRANI</LastName></Author><Author><FirstName>Zohreh</FirstName><LastName>MAZLOOM</LastName></Author><Author><FirstName>Mahmood</FirstName><LastName>SAVID</LastName></Author><Author><FirstName>Ali-Ashraf</FirstName><LastName>RASHIDI</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>05</Day></PubDate></History><Abstract>Background: Atherosclerotic complications are one the most common causes of death in patients with type 2 diabetes mellitus.&amp;nbsp; Epidemiological data indicate that the consumption of omega-3 unsaturated fatty acids (O3FA) leads to a reduction in cardiovascular disorders.&amp;nbsp; The metabolic effect of this substance in patients with type 2 diabetes is still a matter of debate, however.&amp;nbsp; The aim of this study was to assess the metabolic effect of O3FA in Iranian diabetic patients.
Methods: 50 diabetic patients (20 men and 30 women; mean age 49&amp;plusmn;7.3 years) were randomly allocated to either the intervention (diet + fish oil containing O3FA) or the control group (diet alone).&amp;nbsp; The lipid and glucose levels, blood pressure, and weight of each patient were measured at the beginning of the study.&amp;nbsp; The duration of the study was 3 months.&amp;nbsp; The aforementioned parameters were re-assessed at the end of the study.
Results: O3FA consumption was associated with a significant reduction in serum triglyceride levels (p&amp;lt;0.001).&amp;nbsp; Reductions in weight, fasting blood sugar, and glycosylated haemoglobin were noted in the intervention group but were not statistically significant.&amp;nbsp; No changes occurred in total cholesterol, HDL, and LDL levels.&amp;nbsp; The dosage of oral hypoglycaemic agents was unchanged in both groups throughout the study.
Conclusion: O3FA may be recommended for the management of hypertriglyceridaemia.</Abstract><web_url>https://jdmd.tums.ac.ir/index.php/jdmd/article/view/30</web_url></Article></Articles>
